Clinical Trial Update: Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating surgery with either oxaliplatin or mitomycin C for appendiceal tumors and primary peritoneal cancer; the study completed and results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Appendiceal Cancer
• Peritoneal Cancer

Drugs mentioned

• Mitomycin-C (mitomycin C)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Carcinoma of the Appendix, Primary Peritoneal Cavity Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-03-21